3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Colonic Neoplasms
10
Stomach Neoplasms
3
Rectal Neoplasms
3
Carcinoma, Hepatocellular
3
Neoplastic Cells, Circulating
2
Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Stomach Ulcer
1
Prostatic Neoplasms
1
Polyps
1
Patient Satisfaction
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Overweight
1
Ovarian Neoplasms
1
Obesity
1
Melanoma
1
Hypoxia
1
Esophageal Neoplasms
1
Endobronchial Metastases
1
Emergence Delirium
1
Diverticulosis, Colonic
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Interventions
Esomeprazole
3
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
2
Tumor Necrosis Factor-alpha
1
Tetracycline
1
Propofol
1
Physical Examination
1
Omeprazole
1
Lansoprazole
1
Interleukin-10
1
Interleukin-1
1
Gastroscopy
1
Furazolidone
1
Endoscopy, Digestive System
1
Endoscopy
1
Dexlansoprazole
1
Clopidogrel
1
Bismuth
1
Berberine
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Ulcer
×
Propofol
×
Gastrointestinal
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled